Showing results (171-180 of 203) with videos related to

Sort By:
Pageof 21
Oncology|May 27, 1999
A phase I study of paclitaxel and epirubicin, without and with filgrastim, for the treatment of platinum-resistant advanced ovarian cancerR Lauria, E Ferrari, S Tramontana, et al.
ESMO Real World Data and Digital Oncology|February 6, 2026
Establishment of the Campania Oncology Network (Rete Oncologica Campana, ROC): a paradigm shift in oncological care and real world research in the Campania regionE Coppola, I De Santo, A Luongo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 4, 2019
ESMO-ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent diseaseN Colombo, C Sessa, A du Bois, et al.
ESMO Open|March 7, 2024
Under-reporting of subjective symptoms and its prognostic value: a pooled analysis of 12 cancer clinical trialsL Arenare, R Di Liello, P De Placido, et al.
Biochemical Pharmacology|August 8, 2017
Ascites interferes with the activity of lurbinectedin and trabectedin: Potential role of their binding to alpha 1-acid glycoproteinE Erba, M Romano, M Gobbi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 30, 2016
The association of financial difficulties with clinical outcomes in cancer patients: secondary analysis of 16 academic prospective clinical trials conducted in ItalyF Perrone, C Jommi, M Di Maio, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 18, 2012
Serum glutamate levels correlate with Gleason score and glutamate blockade decreases proliferation, migration, and invasion and induces apoptosis in prostate cancer cellsShahriar Koochekpour, Sunipa Majumdar, Gissou Azabdaftari, et al.
Current Cancer Drug Targets|June 29, 2010
Concomitant CXCR4 and CXCR7 expression predicts poor prognosis in renal cancerC D'Alterio, C Consales, M Polimeno, et al.
Cancer Immunology, Immunotherapy : CII|April 17, 2025
Association of peripheral monocytic myeloid-derived suppressor cells with molecular subtypes in single-center endometrial cancer patients receiving carboplatin + paclitaxel/avelumab (MITO-END3 trial)C D'Alterio, G Rea, M Napolitano, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 3, 2021
European experts consensus: BRCA/homologous recombination deficiency testing in first-line ovarian cancerI Vergote, A González-Martín, I Ray-Coquard, et al.
Pageof 21